AI assistant
Sending…
IDEXX LABORATORIES INC /DE — Director's Dealing 2011
Feb 16, 2011
30016_dirs_2011-02-16_b95d6990-644e-45cb-a1d2-c80f1fd2209c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2011-02-14
Reporting Person: Meyaard Daniel V (Corporate Vice President)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-02-14 | Non-Qualified Stock Option (right to buy) | $77.59 | A | 1062 | Acquired | 2018-02-13 | Common Stock (1062) | Direct |
| 2011-02-14 | Incentive Stock Option (right to buy) | $77.59 | A | 6440 | Acquired | 2018-02-13 | Common Stock (6440) | Direct |
| 2011-02-14 | Restricted Stock Unit | $ | A | 806 | Acquired | Common Stock (806) | Direct |
Footnotes
F1: Grant of options to buy shares of common stock that vest in five equal annual installments, beginning on the first anniversary date (02/14/2012) of the date of grant.
F2: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2012) of the date of grant.
More from IDEXX LABORATORIES INC /DE
Regulatory Filings
2026
Jun 1
Declaration of Voting Results & Voting Rights Announcements
2026
May 15
Interim / Quarterly Report
2026
May 5
Earnings Release
2026
May 5
Major Shareholding Notification
2026
Apr 30
Annual Report
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27
Major Shareholding Notification
2026
Mar 27
Board/Management Information
2026
Mar 26